All News about Pharvaris N.V.
![](https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png)
![](https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png)
From Pharvaris N.V.
Via GlobeNewswire
![](/next-assets/images/schema-image-default.png)
What 4 Analyst Ratings Have To Say About Pharvaris
April 06, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png)
![](https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png)
Pharvaris Announces Annual Meeting of Shareholders
June 01, 2023
From Pharvaris N.V.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png)
![](https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png)
![](https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png)
![](https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png)
![](https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png)
Pharvaris to Present in Upcoming March Investor Conferences
March 02, 2023
From Pharvaris N.V.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/02/24/image21.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png)
Pharvaris to Present at SVB Securities Global Biopharma Conference
February 08, 2023
From Pharvaris N.V.
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/01/23/image24.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/11/image20.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png)
Pharvaris Provides Regulatory, Clinical, and Corporate Updates
January 09, 2023
From Pharvaris N.V.
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/01/03/shutterstock_454458619.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/28/image27.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/28/image32.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/28/image47.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/21/image-blackberry.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/09/image_6.jpg?width=1200&height=800&fit=crop)
![](https://schaeffers-cdn.s3.amazonaws.com/images/default-source/schaeffers-cdn-images/2022/december/mmc/mmc-stats-dec-9.jpg?sfvrsn=d684ac06_0)
![](https://cdn.benzinga.com/files/images/story/2022/12/09/image-li_auto.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/09/image_3.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/08/shutterstock_1209068188.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/08/image21_0.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.